Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outset Medical (OM) Net Margin (2019 - 2025)

Outset Medical (OM) has disclosed Net Margin for 7 consecutive years, with 67.5% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 1950.0% to 67.5% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 68.34% through Dec 2025, up 4422.0% year-over-year, with the annual reading at 68.34% for FY2025, 4422.0% up from the prior year.
  • Net Margin for Q4 2025 was 67.5% at Outset Medical, down from 60.61% in the prior quarter.
  • The five-year high for Net Margin was 59.01% in Q2 2025, with the low at 174.96% in Q2 2022.
  • Average Net Margin over 5 years is 117.16%, with a median of 124.01% recorded in 2024.
  • Peak annual rise in Net Margin hit 19168bps in 2021, while the deepest fall reached -18889bps in 2021.
  • Over 5 years, Net Margin stood at 146.46% in 2021, then increased by 12bps to 129.48% in 2022, then rose by 2bps to 126.53% in 2023, then surged by 31bps to 87.01% in 2024, then grew by 22bps to 67.5% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 67.5%, 60.61%, and 59.01% for Q4 2025, Q3 2025, and Q2 2025 respectively.